Comment on "Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients".
Iris K MinichmayrMarkus ZeitlingerPublished in: Clinical pharmacokinetics (2020)
Keyphrases
- intensive care unit
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- clinical trial
- prognostic factors
- randomized controlled trial
- study protocol
- peritoneal dialysis
- molecular docking
- mechanical ventilation
- phase iii
- staphylococcus aureus
- patient reported outcomes
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation